CHARLES SCHWAB INVESTMENT MANAGEMENT INC - DOVA PHARMACEUTICALS INC ownership

DOVA PHARMACEUTICALS INC's ticker is DOVA and the CUSIP is 25985T102. A total of 60 filers reported holding DOVA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of DOVA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$1,491,000
+56.8%
53,310
-20.9%
0.00%0.0%
Q2 2019$951,000
+68.6%
67,386
+6.3%
0.00%
Q1 2019$564,000
+8.0%
63,394
-7.9%
0.00%
Q4 2018$522,000
-64.3%
68,844
-1.4%
0.00%
-100.0%
Q3 2018$1,464,000
+90.1%
69,812
+171.6%
0.00%0.0%
Q2 2018$770,000
+109.8%
25,704
+90.4%
0.00%
Q1 2018$367,000
+28.3%
13,500
+36.4%
0.00%
Q4 2017$286,000
+18.7%
9,9000.0%0.00%
Q3 2017$241,0009,9000.00%
Other shareholders
DOVA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Perceptive Advisors 3,125,851$23,693,0000.90%
Broadfin Capital, LLC 351,800$2,667,0000.35%
Birchview Capital, LP 40,000$303,0000.29%
SPHERA FUNDS MANAGEMENT LTD. 185,000$1,402,0000.16%
Fosun International Ltd 261,780$1,984,0000.12%
Spark Investment Management LLC 61,100$463,0000.03%
Candriam S.C.A. 233,200$1,768,0000.03%
GW&K Investment Management, LLC 178,536$1,353,0000.03%
Tower Research Capital LLC (TRC) 20,613$156,0000.01%
Point72 Hong Kong Ltd 1,456$11,0000.01%
View complete list of DOVA PHARMACEUTICALS INC shareholders